MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with ...

An international expert panel has developed consensus guidelines to help clinicians navigate multiple sclerosis (MS) diagnosis in atypical populations — specifically children and older adults. Here's ...

The biggest difference between ocrelizumab and the recently approved ofatumumab is that ofatumumab can be taken at home for relapsing forms of multiple sclerosis (MS), explained Patricia K. Coyle, MD.

Pain may be an early symptom of MS, with increased gabapentinoid and anticonvulsant prescriptions seen in the years before disease onset. Patients with MS showed higher odds of filling prescriptions ...

An estimated 2.3 million individuals are living with multiple sclerosis (MS) worldwide. Approximately half of all individuals with MS experience changes in cognition such as impaired concentration, ...

Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately ...

Personalizing Cognitive Dysfunction Treatment in Multiple Sclerosis Drs Anne Cross and Lauren Krupp discuss strategies to prolong cognitive function in patients with multiple sclerosis by adopting an ...